Lynn Turner

Following an extended sick-leave, Valeant Pharmaceuticals Intl Inc (NYSE: VRX)'s CEO Mike Pearson has returned to his station at the company's helm. While a call to analysts was cancelled last week, Pearson personally made one-one-one calls to a few analysts, reaching out to those who,...